These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38879488)

  • 1. Inhibition of tartrate-resistant acid phosphatase 5 can prevent cardiac fibrosis after myocardial infarction.
    Yang S; Pei L; Huang Z; Zhong Y; Li J; Hong Y; Long H; Chen X; Zhou C; Zheng G; Zeng C; Wu H; Wang T
    Mol Med; 2024 Jun; 30(1):89. PubMed ID: 38879488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tartrate-resistant acid phosphatase 5 promotes pulmonary fibrosis by modulating β-catenin signaling.
    Hu Y; Wang Q; Yu J; Zhou Q; Deng Y; Liu J; Zhang L; Xu Y; Xiong W; Wang Y
    Nat Commun; 2022 Jan; 13(1):114. PubMed ID: 35013220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR-145 attenuates cardiac fibrosis through the AKT/GSK-3β/β-catenin signaling pathway by directly targeting SOX9 in fibroblasts.
    Cui S; Liu Z; Tao B; Fan S; Pu Y; Meng X; Li D; Xia H; Xu L
    J Cell Biochem; 2021 Feb; 122(2):209-221. PubMed ID: 32890431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MicroRNA-223 Regulates Cardiac Fibrosis After Myocardial Infarction by Targeting RASA1.
    Liu X; Xu Y; Deng Y; Li H
    Cell Physiol Biochem; 2018; 46(4):1439-1454. PubMed ID: 29689569
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exendin-4 Attenuates Remodeling in the Remote Myocardium of Rats After an Acute Myocardial Infarction by Activating β-Arrestin-2, Protein Phosphatase 2A, and Glycogen Synthase Kinase-3 and Inhibiting β-Catenin.
    Eid RA; Khalil MA; Alkhateeb MA; Eleawa SM; Zaki MSA; El-Kott AF; Al-Shraim M; El-Sayed F; Eldeen MA; Bin-Meferij MM; Awaji KME; Shatoor AS
    Cardiovasc Drugs Ther; 2021 Dec; 35(6):1095-1110. PubMed ID: 32474680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of protein phosphatase 2A in a murine model of chronic myocardial infarction leads to increased adverse remodeling but restores the regulation of β-catenin by glycogen synthase kinase 3β.
    Hoehn M; Zhang Y; Xu J; Gergs U; Boknik P; Werdan K; Neumann J; Ebelt H
    Int J Cardiol; 2015 Mar; 183():39-46. PubMed ID: 25662052
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Caffeic acid mitigates myocardial fibrosis and improves heart function in post-myocardial infarction by inhibiting transforming growth factor-β receptor 1 signaling pathways.
    Jiang W; Deng B; Xie M; Feng Y; Jiang X; Yang B; Tan Z; Ou H; Tan Y; Liu S; Zhang S; Zhang J; Zhou Y; Wu W; Liu B
    Biomed Pharmacother; 2024 Aug; 177():117012. PubMed ID: 38906025
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mir-21 Promotes Cardiac Fibrosis After Myocardial Infarction Via Targeting Smad7.
    Yuan J; Chen H; Ge D; Xu Y; Xu H; Yang Y; Gu M; Zhou Y; Zhu J; Ge T; Chen Q; Gao Y; Wang Y; Li X; Zhao Y
    Cell Physiol Biochem; 2017; 42(6):2207-2219. PubMed ID: 28817807
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leonurine Attenuates Myocardial Fibrosis Through Upregulation of miR-29a-3p in Mice Post-myocardial Infarction.
    Wang R; Peng L; Lv D; Shang F; Yan J; Li G; Li D; Ouyang J; Yang J
    J Cardiovasc Pharmacol; 2021 Feb; 77(2):189-199. PubMed ID: 33235025
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amphiregulin enhances cardiac fibrosis and aggravates cardiac dysfunction in mice with experimental myocardial infarction partly through activating EGFR-dependent pathway.
    Liu L; Jin X; Hu CF; Zhang YP; Zhou Z; Li R; Shen CX
    Basic Res Cardiol; 2018 Jan; 113(2):12. PubMed ID: 29349588
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Notch3 Ameliorates Cardiac Fibrosis After Myocardial Infarction by Inhibiting the TGF-β1/Smad3 Pathway.
    Zhang M; Pan X; Zou Q; Xia Y; Chen J; Hao Q; Wang H; Sun D
    Cardiovasc Toxicol; 2016 Oct; 16(4):316-24. PubMed ID: 26487518
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Taohong siwu decoction attenuates myocardial fibrosis by inhibiting fibrosis proliferation and collagen deposition via TGFBR1 signaling pathway.
    Tan Z; Jiang X; Zhou W; Deng B; Cai M; Deng S; Xu Y; Ding W; Chen G; Chen R; Zhang S; Zhou Y; Liu B; Zhang J
    J Ethnopharmacol; 2021 Apr; 270():113838. PubMed ID: 33460756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cardiac Fibroblast-Specific Activating Transcription Factor 3 Promotes Myocardial Repair after Myocardial Infarction.
    Li YL; Hao WJ; Chen BY; Chen J; Li GQ
    Chin Med J (Engl); 2018 Oct; 131(19):2302-2309. PubMed ID: 30246716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DKK3 overexpression attenuates cardiac hypertrophy and fibrosis in an angiotensin-perfused animal model by regulating the ADAM17/ACE2 and GSK-3β/β-catenin pathways.
    Zhai CG; Xu YY; Tie YY; Zhang Y; Chen WQ; Ji XP; Mao Y; Qiao L; Cheng J; Xu QB; Zhang C
    J Mol Cell Cardiol; 2018 Jan; 114():243-252. PubMed ID: 29196099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ghrelin ameliorates cardiac fibrosis after myocardial infarction by regulating the Nrf2/NADPH/ROS pathway.
    Wang Q; Liu AD; Li TS; Tang Q; Wang XC; Chen XB
    Peptides; 2021 Oct; 144():170613. PubMed ID: 34314760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of Cannabinoid Receptor Type II by AM1241 Ameliorates Myocardial Fibrosis via Nrf2-Mediated Inhibition of TGF-β1/Smad3 Pathway in Myocardial Infarction Mice.
    Li X; Han D; Tian Z; Gao B; Fan M; Li C; Li X; Wang Y; Ma S; Cao F
    Cell Physiol Biochem; 2016; 39(4):1521-36. PubMed ID: 27614871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calycosin reduces myocardial fibrosis and improves cardiac function in post-myocardial infarction mice by suppressing TGFBR1 signaling pathways.
    Chen G; Xu H; Xu T; Ding W; Zhang G; Hua Y; Wu Y; Han X; Xie L; Liu B; Zhou Y
    Phytomedicine; 2022 Sep; 104():154277. PubMed ID: 35752078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetylcytidine modification of Amotl1 by N-acetyltransferase 10 contributes to cardiac fibrotic expansion in mice after myocardial infarction.
    Wang XX; Zhao YM; Zhang QY; Zhao JX; Yin DH; Zhang ZZ; Jin XY; Li SN; Ji HY; Chen HY; Guo XF; Yu Y; Ma WY; Yan H; Li H; Ou-Yang QM; Pan ZW; Liang HH; Wang N; Chen W; Cai BZ; Liu Y
    Acta Pharmacol Sin; 2024 Jul; 45(7):1425-1437. PubMed ID: 38839936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Histone methyltransferase DOT1L mediates the TGF-β1/Smad3 signaling pathway through epigenetic modification of SYK in myocardial infarction.
    Li F; Li L; Zhang J; Yang X; Liu Y
    Hum Cell; 2022 Jan; 35(1):98-110. PubMed ID: 34635982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effect of CD137 Deficiency Against Postinfarction Cardiac Fibrosis and Adverse Cardiac Remodeling by ERK1/2 Signaling Pathways.
    Zang G; Chen Y; Guo G; Wan A; Li B; Wang Z
    J Cardiovasc Pharmacol; 2024 May; 83(5):446-456. PubMed ID: 38416872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.